IS-free Treg HaploHCT

Clinical trial NCT04678401 · RECRUITING

Trial details

NCT number: NCT04678401
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Stem Cell Transplant Complications Graft Vs Host Disease Myeloid Leukemia, Acute Myeloid Leukemia in Relapse (Disorder)Myelodysplastic Syndromes

Start date: 2021-01-12
Primary completion: 2028-08-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.